ConductScience.org, home

Paper32150868

Counteracting Radio-Resistance Using the Optimization of Radiotherapy.

Chevalier F. Int J Mol Sci, 2020. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Counteracting Radio-Resistance Using the Optimization of Radiotherapy. Papers, record 32150868. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32150868

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Counteracting Radio-Resistance Using the Optimization of Radiotherapy.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2020
PubMed
Publication types
Editorial
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.5
iCite
Revised in PubMed
2020-12-01
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chevalier FFrançoishttps://orcid.org/0000-0002-8488-2324

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
Radiation ToleranceMajor topic
RadiotherapyMajor topic
Humans

References5

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131349558Radiosensitivity Differences between EGFR Mutant and Wild-Type Lung Cancer Cells are Larger at Lower Doses.Int J Mol Sci2019https://conductscience.org/library/papers/31349558PubMed
231878191Hadrontherapy Interactions in Molecular and Cellular Biology.Int J Mol Sci2019https://conductscience.org/library/papers/31878191PubMed
332023866TiO2 Nanomaterials Non-Controlled Contamination Could Be Hazardous for Normal Cells Located in the Field of Radiotherapy.Int J Mol Sci2020https://conductscience.org/library/papers/32023866PubMed
431540114FGFR Signaling as a Candidate Therapeutic Target for Cancers Resistant to Carbon Ion Radiotherapy.Int J Mol Sci2019https://conductscience.org/library/papers/31540114PubMed
531450688Robustness of Clonogenic Assays as a Biomarker for Cancer Cell Radiosensitivity.Int J Mol Sci2019https://conductscience.org/library/papers/31450688PubMed

Download CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
41044220Effect of blueberry extract on enhancement of radiosensitivity in non-Hodgkin lymphoma by modulating proliferation and apoptosis.Daru2025https://conductscience.org/library/papers/41044220PubMed
40361506Particle Therapy to Overcome Cancer Radiation Resistance: "ARCHADE" Consortium Updates in Radiation Biology.Cancers (Basel)2025https://conductscience.org/library/papers/40361506PubMed
39147708[Research Progress of Engineered Exosomes in the Treatment of Lung Cancer].Zhongguo Fei Ai Za Zhi2024https://conductscience.org/library/papers/39147708PubMed
38920686Potential Benefits of Combining Proton or Carbon Ion Therapy with DNA Damage Repair Inhibitors.Cells2024https://conductscience.org/library/papers/38920686PubMed
37155531Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer.World J Gastroenterol2023https://conductscience.org/library/papers/37155531PubMed
36922504Engineered exosomes from different sources for cancer-targeted therapy.Signal Transduct Target Ther2023https://conductscience.org/library/papers/36922504PubMed
36578381Radiotherapy prognosis-associated gene GCNT3 promotes the proliferation, migration and invasion of lung adenocarcinoma cells.Heliyon2022https://conductscience.org/library/papers/36578381PubMed
36172186Salvia miltiorrhiza in cancer: Potential role in regulating MicroRNAs and epigenetic enzymes.Front Pharmacol2022https://conductscience.org/library/papers/36172186PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
FGFR32261PubTator's text mininghttps://conductscience.org/library/genes/2261NCBI Gene
FGFR42264PubTator's text mininghttps://conductscience.org/library/genes/2264NCBI Gene
GH12688PubTator's text mininghttps://conductscience.org/library/genes/2688NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32150868

GET https://conductscience.org/api/papers/v1/32150868/authors